YOLFTbeta
Sichuan Kelun Pharmaceutical Co Ltd

Sichuan Kelun Pharmaceutical Co Ltd

002422 · SHE · Healthcare / Drug Manufacturers - General

42.67CNY-0.77 (-1.77%)

Price History

Full chart

Market Stats

Previous Close43.44
Open43.17
Day Range42.52 – 43.96
52-Week Range27.75 – 52.78
Volume11.24M
Market Cap64.98B
P/E (TTM)35.52
Forward P/E13.87
EPS1.15
Dividend Yield1.45%
Beta-0.19
50-Day Avg43.03
200-Day Avg36.59

About

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • CEOMr. Sichuan Liu
  • Employees20.13K
  • HeadquartersNo.36 Baihua West Road, Chengdu, China, 610071, China
  • Websitehttps://www.kelun.com

Leadership

  • Mr. Sichuan LiuGM & Director · b. 1984
  • Mr. Degui LaiCFO & Deputy GM · b. 1971
  • Mr. Hao FengDeputy GM & Secretary of the Board of Directors · b. 1980
  • Mr. Zhonghua WuDeputy General Manager · b. 1968
  • Ms. Yihong LiaoDeputy General Manager · b. 1979
  • Lanlan LiSales Manager
  • Mr. Yi FengDeputy GM & Chief Strategy Officer · b. 1966
  • Mr. Deguang ChenOfficer · b. 1971

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.02B2.60B3.22B4.03B5.10B5.89B6.83B8.02B7.76B8.57B11.43B16.35B17.64B16.46B17.28B19.04B21.45B21.81B18.51B
Growth (%)-+29.04%+23.78%+25.03%+26.76%+15.31%+16.07%+17.45%-3.24%+10.34%+33.49%+43.00%+7.86%-6.65%+4.94%+10.19%+12.69%+1.67%-15.13%
Cost of Revenue1.30B1.67B1.99B2.37B3.01B3.42B3.79B4.73B4.55B4.93B5.64B6.68B7.06B7.87B7.99B9.08B10.29B10.61B9.66B
Gross Profit718.57M928.68M1.23B1.65B2.10B2.46B3.05B3.30B3.21B3.63B5.79B9.67B10.57B8.60B9.28B9.95B11.16B11.20B8.86B
Gross Margin35.64%35.70%38.17%41.05%41.11%41.81%44.59%41.07%41.35%42.40%50.65%59.16%59.95%52.22%53.74%52.28%52.03%51.35%47.85%
Operating Expense441.43M528.60M677.63M890.70M1.03B1.22B1.90B2.21B2.64B2.98B4.63B8.32B9.30B7.59B7.96B7.76B7.51B6.77B6.37B
Operating Income277.14M400.08M551.62M762.20M1.07B1.24B1.15B1.09B573.50M653.38M1.16B1.36B1.28B1.01B1.32B2.20B3.65B4.43B2.49B
Operating Margin13.75%15.38%17.13%18.93%20.99%21.01%16.81%13.57%7.39%7.63%10.12%8.29%7.24%6.13%7.64%11.53%17.03%20.29%13.44%
EBITDA335.41M465.37M631.13M922.23M1.38B1.47B1.78B1.91B1.61B1.65B1.93B2.82B2.77B2.38B2.69B3.42B4.60B5.25B3.91B
EBITDA Margin16.64%17.89%19.60%22.90%26.94%24.94%26.05%23.83%20.68%19.22%16.90%17.22%15.68%14.43%15.57%17.94%21.42%24.06%21.10%
Net Income216.29M309.89M427.85M661.23M966.13M1.09B1.08B1.00B645.27M584.64M748.54M1.21B937.86M829.39M1.10B1.71B2.46B2.94B1.70B
Net Income Margin10.73%11.91%13.29%16.42%18.93%18.48%15.80%12.49%8.31%6.83%6.55%7.42%5.32%5.04%6.38%8.96%11.45%13.46%9.19%
R&D11.03M10.43M34.91M71.44M136.43M186.54M400.06M312.35M434.16M547.44M712.21M908.55M1.29B1.53B1.74B1.80B1.94B2.17B2.21B
R&D as % of Total Revenue0.55%0.40%1.08%1.77%2.67%3.17%5.86%3.89%5.59%6.39%6.23%5.56%7.29%9.28%10.05%9.43%9.06%9.95%11.91%
Interest Expense30.68M46.97M46.06M54.53M71.27M138.45M210.36M277.54M318.14M359.47M556.37M632.60M608.94M576.64M532.53M482.21M370.71M154.68M102.84M
Interest Expense % of Total Revenue1.52%1.81%1.43%1.35%1.40%2.35%3.08%3.46%4.10%4.20%4.87%3.87%3.45%3.50%3.08%2.53%1.73%0.71%0.56%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.79B2.66B3.33B8.82B10.47B14.93B17.95B21.20B22.58B23.41B27.99B29.34B31.49B32.01B31.54B34.21B36.45B37.32B39.83B
Total Liabilities1.10B1.47B1.75B1.77B2.53B5.87B7.92B10.23B11.42B11.94B16.01B16.40B17.58B18.01B17.41B17.33B13.44B10.58B10.54B
Total Equity675.09M1.17B1.57B6.99B7.84B8.80B9.76B10.74B11.06B11.33B11.80B12.75B13.19B13.50B13.86B15.73B19.67B22.48B24.22B
Cash103.12M341.21M516.61M4.21B2.09B2.36B2.28B2.03B1.85B1.23B1.23B1.83B2.25B2.77B2.92B4.73B4.68B3.97B6.03B
Total Debt452.40M823.60M1.17B1.08B1.17B3.78B5.57B5.72B5.64B4.21B6.22B8.10B5.32B9.38B6.89B8.05B6.35B3.34B-
Net Debt349.27M482.39M650.89M-3.12B-918.42M1.42B3.29B3.69B3.79B2.98B4.99B6.28B3.07B6.61B3.97B3.32B1.68B-637.42M-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow168.42M221.08M250.69M149.29M342.93M402.77M1.05B1.22B1.24B1.73B1.20B2.95B2.22B2.22B2.85B3.13B5.34B4.49B2.64B
Investing Cash Flow-172.57M-234.48M-319.07M-957.83M-2.61B-2.75B-2.10B-2.99B-2.10B-1.79B-2.38B-959.00M-1.36B-905.28M-1.53B-856.59M-3.37B-1.82B-
Financing Cash Flow21.74M145.53M188.65M4.63B170.50M2.64B947.00M1.13B1.09B-609.61M1.21B-1.38B-467.99M-722.11M-1.27B-407.26M-2.06B-3.30B-
Capital Expenditure175.05M226.58M275.29M647.22M2.00B2.77B2.26B2.76B1.84B1.37B1.48B1.33B1.33B1.23B990.56M896.02M1.77B1.68B1.62B
Free Cash Flow-6.63M-5.50M-24.60M-497.93M-1.66B-2.37B-1.21B-1.54B-600.65M355.95M-374.65M1.62B885.70M988.50M1.86B2.23B3.57B2.81B1.02B
Dividends Paid29.30M50.79M51.04M55.24M216.15M222.39M395.59M503.28M622.10M716.21M647.06M983.94M300.06M602.19M450.05M597.78M1.13B1.81B1.09B
FCF to OCF-3.93%-2.49%-9.81%-333.53%-484.57%-588.61%-115.05%-126.27%-48.46%20.63%-31.14%55.00%39.96%44.54%65.21%71.35%66.85%62.65%38.59%
Dividend Paid to FCF-442.22%-922.74%-207.49%-11.09%-13.01%-9.38%-32.73%-32.70%-103.57%201.21%-172.71%60.58%33.88%60.92%24.24%26.79%31.58%64.36%106.98%

Earnings

Report DateJun 30, 2010Sep 30, 2010Dec 31, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Jul 25, 2014Oct 26, 2014Mar 1, 2015Apr 23, 2015Aug 26, 2015Oct 30, 2015Feb 26, 2016Apr 28, 2016Aug 26, 2016Oct 27, 2016Mar 1, 2017Apr 24, 2017Aug 29, 2017Oct 26, 2017Feb 27, 2018Apr 25, 2018Jul 30, 2018Oct 28, 2018Feb 27, 2019Apr 19, 2019Aug 27, 2019Oct 30, 2019Feb 27, 2020Apr 27, 2020Aug 30, 2020Oct 30, 2020Apr 14, 2021Aug 25, 2021Oct 29, 2021Jan 7, 2022Apr 17, 2022Aug 29, 2022Oct 30, 2022Dec 31, 2022Apr 25, 2023Aug 29, 2023Oct 30, 2023Jan 31, 2024Apr 24, 2024Aug 28, 2024Oct 28, 2024Dec 31, 2024Apr 23, 2025Aug 28, 2025Oct 30, 2025Dec 31, 2025Apr 2, 2026Aug 26, 2026
EPS Estimate-----------------0.390.21-----------0.070.070.090.18--0.210.250.350.230.280.140.240.170.280.230.270.270.360.260.570.400.460.300.700.470.460.410.410.470.450.290.290.31
EPS Actual0.180.130.160.100.180.190.190.120.200.210.220.140.230.220.160.160.210.200.120.140.140.100.070.140.120.110.030.130.040.090.250.250.270.160.130.230.280.130.01-0.010.110.210.230.230.250.180.200.400.350.200.520.390.360.420.670.480.420.290.290.260.120.320.320.42
Surprise------------------48.72%-42.86%-----------257.14%257.14%200.00%-11.11%--33.33%-48.00%-97.14%-104.35%-60.71%50.00%-4.17%35.29%-10.71%-21.74%-25.93%48.15%-2.78%-23.08%-8.77%-2.50%-21.74%40.00%-4.29%2.13%-8.70%-28.87%-29.27%-44.68%-73.33%9.44%10.34%35.48%
Timing----------------Pre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-market-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap64.98B
Enterprise Value61.25B
Trailing P/E35.52
Forward P/E13.87
PEG Ratio1.13
Price / Sales3.56
Price / Book2.69
EPS1.15
Book Value15.48
Revenue (TTM)18.27B
Gross Profit (TTM)8.44B
EBITDA2.76B
Profit Margin10.01%
Operating Margin10.33%
Return on Equity7.49%
Return on Assets2.27%
Shares Outstanding1.59B
Shares Float1.08B
Beta-0.19
Dividend Yield1.45%
Dividend Rate0.59
Payout Ratio50.34%

Dividends

20262×
0.13Oct 21, 20260.47May 11, 2026
20252×
0.13Oct 21, 20250.50Jun 13, 2025
20242×
0.26Oct 23, 20240.80May 29, 2024
20231×
0.62May 15, 2023
20221×
0.43May 16, 2022
20211×
0.32Jul 15, 2021
20201×
0.42May 28, 2020
20191×
0.21Jun 5, 2019
20181×
0.21Jul 30, 2018
20171×
0.14Jun 20, 2017
20161×
0.14Jun 16, 2016
20151×
0.13Jul 22, 2015
20141×
0.08Jul 1, 2014
20131×
0.08May 21, 2013
20121×
0.08Jun 15, 2012
20111×
0.08Apr 29, 2011

Stock Splits

  • Jul 22, 201520:10
  • Jul 1, 201415:10
  • Apr 29, 201120:10